Low-intensity warfarin not noninferior in hip, knee surgery

(HealthDay)—Among older patients undergoing hip or knee replacement, low-intensity compared with standard-intensity warfarin prophylaxis did not meet the noninferiority criterion for the composite outcome of risk of venous ...


Rivaroxaban cuts recurrent blood clots in obese patients

(HealthDay)—Real-world evidence shows that rivaroxaban reduces the risk for recurrent venous thromboembolism (VTE) in morbidly obese patients, with similar safety and efficacy as warfarin, according to a study published ...


History of liver disease does not impact efficacy of edoxaban

(HealthDay)—For patients with atrial fibrillation (AF), the efficacy and safety of edoxaban versus warfarin is not altered with a history of liver disease, according to a study published in the July 16 issue of the Journal ...

page 1 from 15